Post-approval studies (Phase 4)Study completedNCT00192595What this trial is testingTenofovir in HIV/HBV CoinfectionWho this might be right forHIV InfectionHepatitis B Coinfection Kirby Institute 36
Post-approval studies (Phase 4)Study completedNCT06000657What this trial is testingEfficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With EntecavirWho this might be right forHepatitis B, Chronic Daewoong Pharmaceutical Co. LTD. 196
Testing effectiveness (Phase 2)Study completedNCT03577171What this trial is testingA Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)Who this might be right forChronic Hepatitis B Assembly Biosciences 25
Post-approval studies (Phase 4)Study completedNCT00662545What this trial is testingEntecavir Intensification for Persistent HBV Viremia in HIV-HBV InfectionWho this might be right forHIV InfectionsHepatitis B University of California, San Francisco 10
Early research (Phase 1)Study completedNCT00962975What this trial is testingPegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous StudiesWho this might be right forHepatitis B, Chronic Hoffmann-La Roche 29
Not applicableStudy completedNCT01013272What this trial is testingLamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadWho this might be right forHepatitis B, Chronic The University of Hong Kong 50
Not applicableUnknownNCT03214302What this trial is testingThe Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 560
Post-approval studies (Phase 4)Study completedNCT00877760What this trial is testingAugmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis BWho this might be right forChronic Hepatitis B Foundation for Liver Research 184
Early research (Phase 1)Study completedNCT07595159What this trial is testingBW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Shanghai Argo Biopharmaceutical Co., Ltd. 32
Post-approval studies (Phase 4)UnknownNCT04326803What this trial is testingHepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine ResponseWho this might be right forHepatitis B Pontificia Universidad Catolica de Chile 200
Post-approval studies (Phase 4)UnknownNCT01724723What this trial is testingUsing Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentWho this might be right forHepatitisTuberculosishepatitisB National Taiwan University Hospital 50
Large-scale testing (Phase 3)Study completedNCT00114361What this trial is testing48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B Foundation for Liver Research 138
Post-approval studies (Phase 4)Study completedNCT02081469What this trial is testingProphylaxis of CHB Patients With Malignant Tumor Receiving ChemotherapyWho this might be right forHepatitis B, ChronicTumor Chang Gung Memorial Hospital 100
Not applicableStudy completedNCT02005146What this trial is testingRetrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide AnalogsWho this might be right forChronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues Fundación Pública Andaluza Progreso y Salud 86
Not applicableUnknownNCT03680183What this trial is testingClinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)Who this might be right forNon Small Cell Lung CancerHepatitis B Affiliated Cancer Hospital & Institute of Guangzhou Medical University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06537414What this trial is testingSequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)Who this might be right forChronic Hepatitis B Virus InfectionHepatitis B GlaxoSmithKline 283
Early research (Phase 1)Study completedNCT05017116What this trial is testingA Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forChronic Hepatitis B Suzhou Ribo Life Science Co. Ltd. 40
Not applicableLooking for participantsNCT07563309What this trial is testingEvaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid TestWho this might be right forHIV 1 InfectionHIV 2 InfectionSyphilis Infection+1 more bioLytical Laboratories 1,000
Testing effectiveness (Phase 2)Study completedNCT06115993What this trial is testingEvaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) PatientsWho this might be right forHepatitis B, Chronic Ausper Biopharma Co., Ltd. 129
Not applicableEnded earlyNCT01886300What this trial is testingAn Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in VietnamWho this might be right forHepatitis B, Chronic Hoffmann-La Roche 16